Results 41 to 50 of about 1,895,251 (293)
, 2022 PD-Walk dataset for parkinson's disease diagnosis.
Yefei He (12106061), Tao Yang (12106062)
core +1 more source
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression [PDF]
, 2023 Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related morbidity and mortality worldwide. Immune checkpoint inhibitors (ICIs) including anti-PD-1 and anti-PD-L1 antibodies, have significantly changed the treatment outcomes with better ...
Raza, Afsheen +45 more
core +1 more source
استفاده ترکیبی از چند روش در امکان سنجی قابلیت پیاده مداری معابر شهری [PDF]
معماری و شهرسازی ایران, 2019 پیاده مداری اهمیتی اساسی در ادراک هویت فضایی و دریافت کیفیت محیط دارد و به این لحاظ مورد توجه نظریه پردازان متعددی قرار گرفته است. با توجه به تلاش های اخیر برنامه ریزان و طراحان جهت تشویق مردم به پیاده روی، مدل ها و روش های بسیاری جهت امکان سنجی پیاده ...
پویان شهابیان
doaj +1 more source
MoCA and MMSE subitems’ sensitivity across the PD-cognitive spectrum
, 2022 reservedA sample of PD patients was administered MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment). The aim of the study is to determine which MoCA and MMSE subitems are more sensitive in detecting cognitive abnormalities in ...
ZURLO, LETIZIA
core
, 2022 While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source
, 2018 Whole blood was labeled to determine PD-1 and PD-L1 subsets. (A) Histogram plots representatives of one healthy individual and one VL-HIV-1+ individual. PD-L1+ and PD-L1hi were determined in CD4+, in CD8+ and CD19+ cells.
Marjorie Pion (153357) +7 more
core +1 more source
, 2022 While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source
SPION-A-Pd(EDTA) (superparamagnetic iron oxide nanoparticles-A-ethylendiamine tetraacetic acid) as a robust nanocatalyst for Buchwald-Hartwig C-N Coupling Reaction [PDF]
Nanochemistry Research, 2017 During thelast20-30 years, palladium-catalyzed reactions have witnessed tremendous advances in the industrial and organic reactions such as hydrogenation, coupling, cyanation and amination.
Marzieh Ghotbinejad +5 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric intramedullary low‐grade gliomas (PIMLGGs) are rare neoplasms that present unique clinical and management challenges. Although surgery remains the primary tool for tissue diagnosis and decompression, complete gross‐total resection is frequently unfeasible due to the infiltrative nature of these lesions.
Olga M. Sergeenko +5 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak +9 more
wiley +1 more source